The FDA has even approved a drug produced with cannabidiol for that reason (Epidiolex). Although the agency only suggests it for 2 uncommon forms of childhood epilepsy identified as Lennox-Gastaut syndrome and Dravet syndrome. Using these products and solutions at a young age specifically raises